Enhancement of immunomodulatory activity by liposome-encapsulated natural phosphodiester bond CpG-DNA in a human B cell line
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Natural phosphodiester bond CpG-DNA that contains immunomodulatory CpG motifs (PO-DNA) upregulates the expression of proinflammatory cytokines and induces an Ag-driven Th1 response in a CG sequence-dependent manner in mice. In humans, only phosphorothioate backbone-modified CpG-DNA (PS-DNA) and not PO-DNA has immunomodulatory activity. In this study, we found that liposome-encapsulated PO-DNA upregulated the expression of human β-defensin-2(hBD-2) and major histocompatibility class II molecules (HLA-DRA) in a CG sequence-dependent and liposome- dependent manner in human B cells. Of the three different liposomes,DOTAP has the unique ability to enhance the immunomodulatory activity of PO-DNA. In contrast, HLA-DRA and hBD-2 promoter activation can be induced by liposomeencapsulated PS-DNA in a CG sequence-independent manner,depending on the CpG-DNA species. Our observations demonstrate that, when encapsulated with a proper liposome in the immune system, natural PO-DNA has the potential to be a useful therapy for the regulation of the innate immune response.
Abstract
Natural phosphodiester bond CpG-DNA that contains immunomodulatory CpG motifs (PO-DNA) upregulates the expression of proinflammatory cytokines and induces an Ag-driven Th1 response in a CG sequence-dependent manner in mice. In humans, only phosphorothioate backbone-modified CpG-DNA (PS-DNA) and not PO-DNA has immunomodulatory activity. In this study, we found that liposome-encapsulated PO-DNA upregulated the expression of human β-defensin-2(hBD-2) and major histocompatibility class II molecules (HLA-DRA) in a CG sequence-dependent and liposome- dependent manner in human B cells. Of the three different liposomes,DOTAP has the unique ability to enhance the immunomodulatory activity of PO-DNA. In contrast, HLA-DRA and hBD-2 promoter activation can be induced by liposomeencapsulated PS-DNA in a CG sequence-independent manner,depending on the CpG-DNA species. Our observations demonstrate that, when encapsulated with a proper liposome in the immune system, natural PO-DNA has the potential to be a useful therapy for the regulation of the innate immune response.
참고문헌 (33)
- Janeway, C. A. Jr., "Introduction: the role of innate immunity in the adaptive immune response", Semin. Immunol., 10, pp.349~350 (1998)
- Aderem, A., "Toll-like receptors in the induction of the innate immune response", Nature, 406, pp.782~787 (2000)
- Hemmi, H., "A Toll-like receptor recognizes bacterial DNA", Nature, 408, pp.740~745 (2000)
- Krieg, A. M., "Therapeutic potential of Toll-like receptor 9 activation", Nat. Rev. Drug. Discov., 5, pp.471~484 (2006)
- Tokunaga, T., "Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity", J. Natl. Cancer Inst., 72, pp.955~962 (1984)
- Messina, J. P., "Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA", J. Immunol., 147, pp.1759~1764 (1991)
- Krieg, A. M., "CpG motifs in bacterial DNA trigger direct B cell activation", Nature, 374, pp.546~549 (1995)
- Ballas, Z. K., "Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA", J. Immunol., 157, pp.1840~1845 (1996)
- Klinman, D. M., "CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-γ", Proc. Natl. Acad. Sci. U.S.A., 통권 : 93, pp.2879~2883 (1996)
- Krieg, A. M., "CpG motifs in bacterial DNA and their immune effects", Annu. Rev. Immunol., 20, pp.709~760 (2002)
- Kwon, H. J., "NF-κB-dependent regulation of tumor necrosis factor-α gene expression by CpG-oligodeoxynucleotides", Biochem. Biophys. Res. Commun., 311, pp.129~138 (2003)
- Lee, K. W., "Direct role of NF-κB activation in Toll-like receptor-triggered HLA-DRA expression", Eur. J. Immunol., 36, pp.1254~1266 (2006)
- Han, S. H., "Expression of human β-defensin-2 gene induced by CpG-DNA in human B cells", Biochem. Biophys. Res. Commun., 389, pp.443~448 (2009)
- Stein, C. A., "Physicochemical properties of phosphorothioate oligodeoxynucleotides", Nucleic Acids Res., 16, pp.3209~3221 (1988)
- Zhao, Q., "Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides", Antisense Res. Dev., 3, pp.53~66 (1993)
- Zhao, Q., "Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors", Blood, 84, pp.3660~3666 (1994)
- Ballas, Z. K., "Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs", J. Immunol., 167, pp.4878~4886 (2001)
- Broide, D., "Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice", J. Immunol., 161, pp.7054~7063 (1998)
- Zimmermann, S., "CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis", J. Immunol., 160, pp.3627~3630 (1998)
- Sparwasser, T., "Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis", J. Immunol., 162, pp.2368~2374 (1999)
- Heikenwalder, M., "Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration", Nat. Med., 10, pp.187~192 (2004)
- Deng, G. M., "Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis", Nat. Med., 5, pp.702~705 (1999)
- Kim, D., "Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA", Biochem. Biophys. Res. Commun., 379, pp.362~367 (2009)
- Lee, K. W., "Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA", Mol. Immunol., 43, pp.2107~2118 (2006)
- Yasuda, K., "Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways", J. Immunol., 174, pp.6129~6136 (2005)
- Magnusson, M., "Natural DNA repetitive extragenic sequences from Gramnegative pathogens strongly stimulate TLR9", J. Immunol., 179, pp.31~35 (2007)
- Choi, Y. J., "Identification of immunostimulatory oligodeoxynucleotides from Escherichia coli genomic DNA", J. Biochem. Mol. Biol., 39, pp.788~793 (2006)
- Chikh, G., "Liposomal delivery of CTL epitope to dendritic cells", Bioscience Reports, 22, pp.339~353 (2002)
- Felnerova, D., "Liposomes and virosomes as delivery system for antigens, nucleic acids and drugs", Curr. Opin. Biotechnol., 15, pp.518~529 (2004)
- Chu, R. S., "CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity", J. Exp. Med., 186, pp.1623~1631 (1997)
- Davis, H. L., "CpG-DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen", J. Immunol., 160, pp.870~876 (1998)
- Suzuki, Y., "Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity", Cancer Res., 64, pp.8754~8760 (2004)
- Soohyoung Lee, "Inhibitory effects of flavonoids on TNF-α-induced IL-8 gene expression in HEK 293 cells", BMB reports, 42(5), pp.265~270 (2009), 한국생화학분자생물학회